Some studies show GLP-1s reduce ALT levels, with maximum impact around 30 weeks of treatment
For T2D indications, RxSS has 80 suggestions related to semaglutide, liraglutide and tirzepatide
The results indicated that GSH levels in blood increased significantly after one, three, and six months compared to baseline in both the low-dose and high-dose GSH groups, while no such increase was observed in the placebo group
Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update Revisin crtica reciente que actualiz la literatura disponible sobre el uso del compuesto en deterioro cognitivo primario y secundario, incluyendo el eje gut-liver-brain
Color change
Ghosh AK, Mau T, OBrien M, Garg S, Yung R